This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
Mile High Labs has closed a Series B equity financing round from American entrepreneur John Paul DeJoria. The financing will be used to pay off existing debt and accelerate the development of its manufacturing and formulations platform.
In order to help bring the benefits of CBD and other non-psychoactive cannabinoids to a wider, national audience unencumbered by federal restriction, the industry needs to provide data assuring the ingredients’ safety.
The U.S. Food and Drug Administration has approved Epidiolex (cannabidiol) oral solution for the treatment of seizures associated with tuberous sclerosis complex, a genetic disorder characterized by growth of numerous noncancerous tumors.
Today, medical cannabis is approved for use in 33 U.S. states plus the District of Columbia, and several other states have medical or recreational cannabis legalization on the fall election ballot.
Charlotte’s Web, in partnership with Studio Number One, has unveiled a 76-acre art installation in a farmer’s field in McPherson, Kansas as part of its “Trust The Earth” initiative.
Cannabis Global, Inc. says it has successfully applied production techniques developed for tetrahydrocannabivarin (THC-V) to cannabinol (CBN), another rare cannabinoid the company believes has growth potential as a new cannabinoid-based products market.
Healthy Food Ingredients (HFI) is entering a strategic supply partnership with KND Labs, producer of hemp-derived cannabinoids such as cannabidiol (CBD), cannabigerol (CBG) and cannabinol (CBN).
Perrigo Company plc is entering the cannabidiol (CBD) market through a strategic investment in and long-term supply agreement with Kazmira LLC, a leading supplier of hemp-based CBD products.